Suppr超能文献

一步离子交换层析复性 MHC/肽复合物的鉴定。

Characterization of MHC/peptide complexes refolded by a one-step ion-exchange chromatography.

机构信息

Key Laboratory of Developmental Genes and Human Disease, Ministry of Education, Southeast University School of Medicine, Nanjing, Jiangsu, China.

出版信息

J Immunol Methods. 2011 Jun 30;369(1-2):81-90. doi: 10.1016/j.jim.2011.04.014. Epub 2011 May 17.

Abstract

The current refolding process of MHC/peptide complexes is low-yield and time-consuming, thereby limiting the wide uses of MHC/peptide multimers. Here the heavy chain protein of MHC/peptide complex (H-2K(b)/TRP2(180-188)) was immobilized onto an ion-exchange chromatography column, and the β2m or TRP2(180-188)-fused β2m protein, which renatured previously in refolding buffer, was able to pass through the column for the gradient refolding. This strategy refolds, concentrates and purifies MHC/peptide complexes in a single integrated step, achieving a high level of process simplification and automation. Using this on-column refolding method, MHC/peptide complexes could be prepared within 24h with a refolding yield of over 20%. Anti-H-2K(b) mAb staining and flow cytometric analyses revealed that the on-column refolded H-2K(b)/TRP2(180-188) complexes had conformational characteristics similar to the dilution refolded H-2K(b)/TRP2(180-188) complexes and the commercial ones. Furthermore, H-2K(b)/TRP2(180-188) tetramer staining and the enumeration of TRP2(180-188)-specific T cells and H-2K(b)-alloreactive T cells confirmed that the H-2K(b)/TRP2(180-188) complexes prepared by on-column refolding or dilution refolding had comparable TCR-binding ability. These data demonstrate a novel, simple and efficient refolding strategy for the generation of MHC class I/peptide complexes.

摘要

目前 MHC/肽复合物的复性过程产量低、耗时长,从而限制了 MHC/肽多聚体的广泛应用。本研究将 MHC/肽复合物(H-2K(b)/TRP2(180-188))的重链蛋白固定在离子交换层析柱上,先前在复性缓冲液中复性的β2m 或 TRP2(180-188)-融合β2m 蛋白能够通过该柱进行梯度复性。这种策略在单个集成步骤中复性、浓缩和纯化 MHC/肽复合物,实现了高度简化和自动化的过程。使用这种柱上复性方法,MHC/肽复合物可在 24 小时内制备,复性产率超过 20%。抗 H-2K(b) mAb 染色和流式细胞术分析表明,柱上复性的 H-2K(b)/TRP2(180-188)复合物具有与稀释复性的 H-2K(b)/TRP2(180-188)复合物和商业复合物相似的构象特征。此外,H-2K(b)/TRP2(180-188)四聚体染色和 TRP2(180-188)-特异性 T 细胞和 H-2K(b)-同种反应性 T 细胞的计数证实,通过柱上复性或稀释复性制备的 H-2K(b)/TRP2(180-188)复合物具有可比的 TCR 结合能力。这些数据表明,这是一种用于生成 MHC Ⅰ类/肽复合物的新型、简单、有效的复性策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验